Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boon Cher Goh

Showing results (111-120 of 242) with videos related to

Pageof 25
Sort By:
Redox Biology|January 16, 2019
Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistanceJayshree Hirpara, Jie Qing Eu, Joanna Kia Min Tan, et al.
Investigational New Drugs|September 14, 2007
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cellsBrigette Ma, Boon Cher Goh, Eng Huat Tan, et al.
Biomarker Research|March 11, 2022
Clinical translation of patient-derived tumour organoids- bottlenecks and strategiesMalia Alexandra Foo, Mingliang You, Shing Leng Chan, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 27, 2011
Method development and validation for rapid quantification of hydroxychloroquine in human blood using liquid chromatography-tandem mass spectrometryLing-Zhi Wang, Rina Yue-Ling Ong, Tan-Min Chin, et al.
Pharmacological Research|February 19, 2020
A unique CDK4/6 inhibitor: Current and future therapeutic strategies of abemaciclibQing-Yun Chong, Ze-Hui Kok, Ngoc-Linh-Chi Bui, et al.
Plos One|March 21, 2015
Validation of a rapid and sensitive LC-MS/MS method for determination of exemestane and its metabolites, 17β-hydroxyexemestane and 17β-hydroxyexemestane-17-O-β-D-glucuronide: application to human pharmacokinetics studyLing-Zhi Wang, Sok-Hwei Goh, Andrea Li-Ann Wong, et al.
Cancer Letters|May 30, 2021
Resveratrol for cancer therapy: Challenges and future perspectivesBoxu Ren, Marabeth Xin-Yi Kwah, Cuiliu Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2002
Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategiesBoon-Cher Goh, Soo-Chin Lee, Ling-Zhi Wang, et al.
Clinical Chemistry|November 18, 2006
Detection of epidermal growth factor receptor variations by partially denaturing HPLCTan Min Chin, Diyanah Anuar, Ross Soo, et al.
Antioxidants & Redox Signaling|November 17, 2020
Targeting Hypoxia-Inducible Factor-1-Mediated Metastasis for Cancer TherapyZhaowu Ma, Louis Zizhao Wang, Jun-Ting Cheng, et al.
Pageof 25

Showing results (111-120 of 242) with videos related to

Sort By:
Pageof 25
Redox Biology|January 16, 2019
Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistanceJayshree Hirpara, Jie Qing Eu, Joanna Kia Min Tan, et al.
Investigational New Drugs|September 14, 2007
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cellsBrigette Ma, Boon Cher Goh, Eng Huat Tan, et al.
Biomarker Research|March 11, 2022
Clinical translation of patient-derived tumour organoids- bottlenecks and strategiesMalia Alexandra Foo, Mingliang You, Shing Leng Chan, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 27, 2011
Method development and validation for rapid quantification of hydroxychloroquine in human blood using liquid chromatography-tandem mass spectrometryLing-Zhi Wang, Rina Yue-Ling Ong, Tan-Min Chin, et al.
Pharmacological Research|February 19, 2020
A unique CDK4/6 inhibitor: Current and future therapeutic strategies of abemaciclibQing-Yun Chong, Ze-Hui Kok, Ngoc-Linh-Chi Bui, et al.
Plos One|March 21, 2015
Validation of a rapid and sensitive LC-MS/MS method for determination of exemestane and its metabolites, 17β-hydroxyexemestane and 17β-hydroxyexemestane-17-O-β-D-glucuronide: application to human pharmacokinetics studyLing-Zhi Wang, Sok-Hwei Goh, Andrea Li-Ann Wong, et al.
Cancer Letters|May 30, 2021
Resveratrol for cancer therapy: Challenges and future perspectivesBoxu Ren, Marabeth Xin-Yi Kwah, Cuiliu Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2002
Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategiesBoon-Cher Goh, Soo-Chin Lee, Ling-Zhi Wang, et al.
Clinical Chemistry|November 18, 2006
Detection of epidermal growth factor receptor variations by partially denaturing HPLCTan Min Chin, Diyanah Anuar, Ross Soo, et al.
Antioxidants & Redox Signaling|November 17, 2020
Targeting Hypoxia-Inducible Factor-1-Mediated Metastasis for Cancer TherapyZhaowu Ma, Louis Zizhao Wang, Jun-Ting Cheng, et al.
Pageof 25